Curative Analysis of 60 Cases with Acute Progressing Cerebral Infarction Treated with Low Molecular Weight Heparin
Zeng Huanping
Abstract
Zeng Huanping
Abstract
Objective To observe the curative effect of acute progressing cerebral infarction treated with low molecular weight heparin(LMWH). Methods To divide 120 acute progressing cerebral infarction patients (in 6 to 48 hours) into two groups randomly, the patients in the treatment group(n=60)were given extra treatment of low molecular weight heparin on the basis of routine therapy and ordinary treatment was adopted in the control group. The lab index and the deficiency grading of nervous function before and after treatment were studied and those of the two groups were compared,and a statistical analysis was made to compare the therapeutic effect for 4 weeks. Results The overall effective rate of the treatment group was higher than that of the control group (P0.05). Conclusion It is quite effective,convenient,safe and economical to use low molecular weight heparin in acute progressing cerebral infarction. It is worthily recommended in the clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the curative effect of acute progressing cerebral infarction treated with low molecular weight heparin(LMWH). Methods To divide 120 acute progressing cerebral infarction patients (in 6 to 48 hours) into two groups randomly, the patients in the treatment group(n=60)were given extra treatment of low molecular weight heparin on the basis of routine therapy and ordinary treatment was adopted in the control group. The lab index and the deficiency grading of nervous function before and after treatment were studied and those of the two groups were compared,and a statistical analysis was made to compare the therapeutic effect for 4 weeks. Results The overall effective rate of the treatment group was higher than that of the control group (P0.05). Conclusion It is quite effective,convenient,safe and economical to use low molecular weight heparin in acute progressing cerebral infarction. It is worthily recommended in the clinical application.
Key concepts: Medicine, Low molecular weight heparin, Heparin, Cerebral infarction, Grading (engineering), Anesthesia, Infarction, Surgery